CONCLUSION
In this randomized controlled trial, we report how urologists' treatment preference for prostatectomy/radiation increased in men who received GPS score. These findings demonstrate how obtaining prognostic biomarkers at the time of diagnosis might influence urologists' preference for recommending immediate therapy, especially in high‐risk populations.